149 related articles for article (PubMed ID: 2731447)
1. Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients.
Trujillo H; Harry N; Arango A; Benítez G; Restrepo F; Mejía GI; Castrillón AL
Chemotherapy; 1989; 35 Suppl 1():25-30. PubMed ID: 2731447
[TBL] [Abstract][Full Text] [Related]
2. Aztreonam in the treatment of gram-negative meningitis and other gram-negative infections.
Feris J; Moledina N; Rodriguez WJ; Khan WN; Puig J; Wiedermann BL; Ahmad S
Chemotherapy; 1989; 35 Suppl 1():31-8. PubMed ID: 2731448
[TBL] [Abstract][Full Text] [Related]
3. Successful response of severe neonatal gram-negative infection to treatment with aztreonam.
Constantopoulos A; Thomaidou L; Loupa H; Papoulias G
Chemotherapy; 1989; 35 Suppl 1():101-5. PubMed ID: 2731446
[TBL] [Abstract][Full Text] [Related]
4. Aztreonam in gram-negative infections in children.
Sklavunu-Tsurutsoglu S; Gatzola-Karaveli M; Hitoglu-Makedu A; Paradelis AG; Tsurutsoglu G
Chemioterapia; 1987 Jun; 6(2 Suppl):415-7. PubMed ID: 3509461
[No Abstract] [Full Text] [Related]
5. The use of aztreonam in pediatric patients: a review.
Bosso JA; Black PG
Pharmacotherapy; 1991; 11(1):20-5. PubMed ID: 1902290
[TBL] [Abstract][Full Text] [Related]
6. Aztreonam therapy for serious gram-negative infections in children.
Stutman HR; Chartrand SA; Tolentino T; Friedhoff L; Marks MI
Am J Dis Child; 1986 Nov; 140(11):1147-51. PubMed ID: 3766490
[TBL] [Abstract][Full Text] [Related]
7. Aztreonam in the treatment of gram-negative bacterial meningitis.
Lentnek AL; Williams RR
Rev Infect Dis; 1991; 13 Suppl 7():S586-90. PubMed ID: 2068463
[TBL] [Abstract][Full Text] [Related]
8. Aztreonam for treating meningitis caused by gram-negative rods.
Kilpatrick M; Girgis N; Farid Z; Bishay E
Scand J Infect Dis; 1991; 23(1):125-6. PubMed ID: 2028226
[TBL] [Abstract][Full Text] [Related]
9. Aztreonam therapy for serious gram-negative bacillary infections.
Cone LA; Woodard DR
Rev Infect Dis; 1985; 7 Suppl 4():S794-802. PubMed ID: 3909339
[TBL] [Abstract][Full Text] [Related]
10. Aztreonam in the treatment of bacterial meningitis.
Ayroza-Galvão PA; Milstein-Kuschnaroff TM; Mimica IM; Maassen S; Barbosa Júnior SP; Cavalcante NJ; Lorenco R; Mimica LM; Martino MD
Chemotherapy; 1989; 35 Suppl 1():39-44. PubMed ID: 2731449
[TBL] [Abstract][Full Text] [Related]
11. [Clinical efficacy of aztreonam in refractory infections in children].
Ogura H; Hamada F; Fujieda M; Matsumoto K; Araki K; Ogura Y; Kuramitsu M; Kurashige T; Kitamura I
Jpn J Antibiot; 1985 Nov; 38(11):3349-57. PubMed ID: 4094068
[TBL] [Abstract][Full Text] [Related]
12. A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections.
Rivera-Vazquez CR; Ramirez-Ronda CH; Rodriguez JR; Saavedra S
Chemotherapy; 1989; 35 Suppl 1():89-100. PubMed ID: 2659296
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria.
McKellar PP
Rev Infect Dis; 1985; 7 Suppl 4():S803-9. PubMed ID: 3909340
[TBL] [Abstract][Full Text] [Related]
14. Use of aztreonam in patients suffering from urinary tract infections with contraindications for the use of aminoglycosides.
Fraschini F; Scaglione F; Alessandria M; Gattei G
Chemioterapia; 1986 Oct; 5(5):319-21. PubMed ID: 3791478
[TBL] [Abstract][Full Text] [Related]
15. Aztreonam: review of the clinical experience and potential uses in pediatrics.
Lebel MH; McCracken GH
Pediatr Infect Dis J; 1988 May; 7(5):331-9. PubMed ID: 3288947
[No Abstract] [Full Text] [Related]
16. Clinical experience with aztreonam for treatment of infections in children.
Stutman HR
Rev Infect Dis; 1991; 13 Suppl 7():S582-5. PubMed ID: 2068462
[TBL] [Abstract][Full Text] [Related]
17. Aztreonam in the treatment of urinary tract infections: a multicenter trial.
Martelli A; Cortecchia V; Ventriglia L
Chemotherapy; 1989; 35 Suppl 1():8-14. PubMed ID: 2659294
[TBL] [Abstract][Full Text] [Related]
18. [Fundamental and clinical studies on aztreonam in the pediatric field].
Iwai N; Taneda Y; Shibata M; Mizoguchi F; Nakamura H; Katayama M
Jpn J Antibiot; 1985 Nov; 38(11):3273-84. PubMed ID: 4094059
[TBL] [Abstract][Full Text] [Related]
19. Gram-negative bacillary pneumonia in the nosocomial setting. Role of aztreonam therapy.
Cook JL
Am J Med; 1990 Mar; 88(3C):34S-37S; discussion 38S-42S. PubMed ID: 2316557
[TBL] [Abstract][Full Text] [Related]
20. [Bacteriological, pharmacokinetic and clinical studies on aztreonam in the pediatric field. Pediatric Study Group of Aztreonam].
Fuyii R; Meguro H; Arimasu O; Sunakawa K; Ishizuka Y; Nakazawa S; Sato H; Narita A; Matsumoto K; Suzuki H
Jpn J Antibiot; 1985 Nov; 38(11):3195-216. PubMed ID: 3912524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
